Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
2025 Q4 -tulosraportti
83 päivää sitten
7,95 DKK/osake
Viimeisin osinko
4,44%Tuotto/v

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
21--
97--
170--
2--
150--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
DnB Bank ASA50 00050 000050 000
Anonyymi1 770 4491 770 44900

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
DnB Bank ASA50 00050 000050 000
Anonyymi1 770 4491 770 44900

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
6.5.
Menneet tapahtumat
Vuosittainen yhtiökokous 2026
26.3.
2025 Q4 -tulosraportti
4.2.
Ylimääräinen yhtiökokous 2025
14.11.2025
2025 Q3 -tulosraportti
5.11.2025
2025 Q2 -tulosraportti
6.8.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 54 min sitten
    ·
    54 min sitten
    ·
    Regarding Novo's Q1 guidance, it has been discussed whether it was too conservative or not. I lean towards conservative because I believe it would have been strategically unwise for Mike and management not to deliver on the first guidance when one is at the top. BUT, another thing I've thought about that perhaps supports the motivation to guide weaker than one actually believes in. ..and that is the price negotiations with the Trump administration. Novo (and Eli) must have argued that too low pricing would negatively impact their business. A bit of crisis exaggeration during the negotiations. It would have looked strange if, shortly after such negotiations, they still guided 0-growth or growth. This is pure speculation, but the thought has struck me
    49 min sitten
    ·
    49 min sitten
    ·
    To falsify a company's guidance (economic expectations for the future) is a serious form of stock market fraud and accounting fraud. If that is the case, then NN has a huge problem.
    14 min sitten · Muokattu
    ·
    14 min sitten · Muokattu
    ·
    There are no limits to what one can read here. As I experience..... Hope it becomes a good investment one day.
  • 1 t sitten
    ·
    1 t sitten
    ·
    Eli Lilly's Q1 results on Thursday - how might the Novo share be affected? Instinctively, one might think that a weak Q1 for Eli benefits Novo, but I think a bit differently.. if Eli delivers a weak quarter, won't analysts/funds think that price pressure is the reason and that Novo will very likely also be affected on May 6th? "Perhaps we have overestimated the market potential in the obesity segment?" one might wonder... An expected report, on the other hand, probably also benefits Novo (?), showing that growth is still possible even with large price reductions. I'm unsure. Any thoughts on this?
    12 min sitten
    ·
    12 min sitten
    ·
    I believe novo could be pulled down if the revenue impact is too high compared to the reduced prices, as parallels can be drawn. If it is as expected, I think there could be a positive outcome for novo based on the extremely positive start for oral wegovy.
  • 1 t sitten · Muokattu
    ·
    1 t sitten · Muokattu
    ·
    The news about an upcoming obesity congress here on Nordnet. Here is one of the points: presentation of the following. Are we risking another own goal like the previous study with competitor comparison? ORION: Oral Semaglutide vs Orforglipron in Obesity -- An Indirect Comparison. Oral presentation -- Friday 15 May; 10:00--10:10 (encore)
    25 min sitten
    ·
    25 min sitten
    ·
    We just have to cross our fingers that they have become wiser.
  • 1 t sitten · Muokattu
    ·
    1 t sitten · Muokattu
    ·
    I always greatly appreciate warnings against my investments, but warnings need to be supported by arguments - just as if someone wants to tip me off about good buys. I put together some clips from posts over the last 4 days from a user here who came with a lot of warnings to us, but I miss arguments. It shines through that the person has an agenda, either bet on another horse or trading bear certificates... To avoid such ultra-assertive posts would be nice.. be critical but it's good if one also says why - so that the posts don't look like they were written by a 14-year-old with behavioral problems. Friday... "I wonder if we can't say again: up like a deer, down like a turd??" "Yes, impending downturn on Monday wait and see." "Ah, I just think we should first see the reaction after May 6th. It will be horrible and we almost already know it in advance." "Who didn't get out before the weekend ??" "Weak ?? the stock has no momentum anymore I think most people expect a big decline on May 6th." "You'll see soon." "Well, my confidence will grow in the next 10 days ;-)" "Hmm, there's nothing pulling the other way??"
    7 min sitten
    ·
    7 min sitten
    ·
    Where the hell are they all, when we have the bragging rights 😊
    Alle minuutti sitten
    Alle minuutti sitten
    😅😅
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti
83 päivää sitten
7,95 DKK/osake
Viimeisin osinko
4,44%Tuotto/v

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 54 min sitten
    ·
    54 min sitten
    ·
    Regarding Novo's Q1 guidance, it has been discussed whether it was too conservative or not. I lean towards conservative because I believe it would have been strategically unwise for Mike and management not to deliver on the first guidance when one is at the top. BUT, another thing I've thought about that perhaps supports the motivation to guide weaker than one actually believes in. ..and that is the price negotiations with the Trump administration. Novo (and Eli) must have argued that too low pricing would negatively impact their business. A bit of crisis exaggeration during the negotiations. It would have looked strange if, shortly after such negotiations, they still guided 0-growth or growth. This is pure speculation, but the thought has struck me
    49 min sitten
    ·
    49 min sitten
    ·
    To falsify a company's guidance (economic expectations for the future) is a serious form of stock market fraud and accounting fraud. If that is the case, then NN has a huge problem.
    14 min sitten · Muokattu
    ·
    14 min sitten · Muokattu
    ·
    There are no limits to what one can read here. As I experience..... Hope it becomes a good investment one day.
  • 1 t sitten
    ·
    1 t sitten
    ·
    Eli Lilly's Q1 results on Thursday - how might the Novo share be affected? Instinctively, one might think that a weak Q1 for Eli benefits Novo, but I think a bit differently.. if Eli delivers a weak quarter, won't analysts/funds think that price pressure is the reason and that Novo will very likely also be affected on May 6th? "Perhaps we have overestimated the market potential in the obesity segment?" one might wonder... An expected report, on the other hand, probably also benefits Novo (?), showing that growth is still possible even with large price reductions. I'm unsure. Any thoughts on this?
    12 min sitten
    ·
    12 min sitten
    ·
    I believe novo could be pulled down if the revenue impact is too high compared to the reduced prices, as parallels can be drawn. If it is as expected, I think there could be a positive outcome for novo based on the extremely positive start for oral wegovy.
  • 1 t sitten · Muokattu
    ·
    1 t sitten · Muokattu
    ·
    The news about an upcoming obesity congress here on Nordnet. Here is one of the points: presentation of the following. Are we risking another own goal like the previous study with competitor comparison? ORION: Oral Semaglutide vs Orforglipron in Obesity -- An Indirect Comparison. Oral presentation -- Friday 15 May; 10:00--10:10 (encore)
    25 min sitten
    ·
    25 min sitten
    ·
    We just have to cross our fingers that they have become wiser.
  • 1 t sitten · Muokattu
    ·
    1 t sitten · Muokattu
    ·
    I always greatly appreciate warnings against my investments, but warnings need to be supported by arguments - just as if someone wants to tip me off about good buys. I put together some clips from posts over the last 4 days from a user here who came with a lot of warnings to us, but I miss arguments. It shines through that the person has an agenda, either bet on another horse or trading bear certificates... To avoid such ultra-assertive posts would be nice.. be critical but it's good if one also says why - so that the posts don't look like they were written by a 14-year-old with behavioral problems. Friday... "I wonder if we can't say again: up like a deer, down like a turd??" "Yes, impending downturn on Monday wait and see." "Ah, I just think we should first see the reaction after May 6th. It will be horrible and we almost already know it in advance." "Who didn't get out before the weekend ??" "Weak ?? the stock has no momentum anymore I think most people expect a big decline on May 6th." "You'll see soon." "Well, my confidence will grow in the next 10 days ;-)" "Hmm, there's nothing pulling the other way??"
    7 min sitten
    ·
    7 min sitten
    ·
    Where the hell are they all, when we have the bragging rights 😊
    Alle minuutti sitten
    Alle minuutti sitten
    😅😅
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
21--
97--
170--
2--
150--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
DnB Bank ASA50 00050 000050 000
Anonyymi1 770 4491 770 44900

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
DnB Bank ASA50 00050 000050 000
Anonyymi1 770 4491 770 44900

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
6.5.
Menneet tapahtumat
Vuosittainen yhtiökokous 2026
26.3.
2025 Q4 -tulosraportti
4.2.
Ylimääräinen yhtiökokous 2025
14.11.2025
2025 Q3 -tulosraportti
5.11.2025
2025 Q2 -tulosraportti
6.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti
83 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
6.5.
Menneet tapahtumat
Vuosittainen yhtiökokous 2026
26.3.
2025 Q4 -tulosraportti
4.2.
Ylimääräinen yhtiökokous 2025
14.11.2025
2025 Q3 -tulosraportti
5.11.2025
2025 Q2 -tulosraportti
6.8.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

7,95 DKK/osake
Viimeisin osinko
4,44%Tuotto/v

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 54 min sitten
    ·
    54 min sitten
    ·
    Regarding Novo's Q1 guidance, it has been discussed whether it was too conservative or not. I lean towards conservative because I believe it would have been strategically unwise for Mike and management not to deliver on the first guidance when one is at the top. BUT, another thing I've thought about that perhaps supports the motivation to guide weaker than one actually believes in. ..and that is the price negotiations with the Trump administration. Novo (and Eli) must have argued that too low pricing would negatively impact their business. A bit of crisis exaggeration during the negotiations. It would have looked strange if, shortly after such negotiations, they still guided 0-growth or growth. This is pure speculation, but the thought has struck me
    49 min sitten
    ·
    49 min sitten
    ·
    To falsify a company's guidance (economic expectations for the future) is a serious form of stock market fraud and accounting fraud. If that is the case, then NN has a huge problem.
    14 min sitten · Muokattu
    ·
    14 min sitten · Muokattu
    ·
    There are no limits to what one can read here. As I experience..... Hope it becomes a good investment one day.
  • 1 t sitten
    ·
    1 t sitten
    ·
    Eli Lilly's Q1 results on Thursday - how might the Novo share be affected? Instinctively, one might think that a weak Q1 for Eli benefits Novo, but I think a bit differently.. if Eli delivers a weak quarter, won't analysts/funds think that price pressure is the reason and that Novo will very likely also be affected on May 6th? "Perhaps we have overestimated the market potential in the obesity segment?" one might wonder... An expected report, on the other hand, probably also benefits Novo (?), showing that growth is still possible even with large price reductions. I'm unsure. Any thoughts on this?
    12 min sitten
    ·
    12 min sitten
    ·
    I believe novo could be pulled down if the revenue impact is too high compared to the reduced prices, as parallels can be drawn. If it is as expected, I think there could be a positive outcome for novo based on the extremely positive start for oral wegovy.
  • 1 t sitten · Muokattu
    ·
    1 t sitten · Muokattu
    ·
    The news about an upcoming obesity congress here on Nordnet. Here is one of the points: presentation of the following. Are we risking another own goal like the previous study with competitor comparison? ORION: Oral Semaglutide vs Orforglipron in Obesity -- An Indirect Comparison. Oral presentation -- Friday 15 May; 10:00--10:10 (encore)
    25 min sitten
    ·
    25 min sitten
    ·
    We just have to cross our fingers that they have become wiser.
  • 1 t sitten · Muokattu
    ·
    1 t sitten · Muokattu
    ·
    I always greatly appreciate warnings against my investments, but warnings need to be supported by arguments - just as if someone wants to tip me off about good buys. I put together some clips from posts over the last 4 days from a user here who came with a lot of warnings to us, but I miss arguments. It shines through that the person has an agenda, either bet on another horse or trading bear certificates... To avoid such ultra-assertive posts would be nice.. be critical but it's good if one also says why - so that the posts don't look like they were written by a 14-year-old with behavioral problems. Friday... "I wonder if we can't say again: up like a deer, down like a turd??" "Yes, impending downturn on Monday wait and see." "Ah, I just think we should first see the reaction after May 6th. It will be horrible and we almost already know it in advance." "Who didn't get out before the weekend ??" "Weak ?? the stock has no momentum anymore I think most people expect a big decline on May 6th." "You'll see soon." "Well, my confidence will grow in the next 10 days ;-)" "Hmm, there's nothing pulling the other way??"
    7 min sitten
    ·
    7 min sitten
    ·
    Where the hell are they all, when we have the bragging rights 😊
    Alle minuutti sitten
    Alle minuutti sitten
    😅😅
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
21--
97--
170--
2--
150--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
DnB Bank ASA50 00050 000050 000
Anonyymi1 770 4491 770 44900

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
DnB Bank ASA50 00050 000050 000
Anonyymi1 770 4491 770 44900
© 2026 Nordnet Bank AB.
Nordnet | Alvar Aallon katu 5 C, 3. krs | FI-00100 Helsinki